Type III CRISPR–Cas systems produce cyclic oligoadenylate second messengersOle Niewoehner, Martin Jínek, Frank Schwede et al.|Nature|2017Cited by 504
A phage-encoded anti-CRISPR enables complete evasion of type VI-A CRISPR-Cas immunityAlexander J. Meeske, Luciano A. Marraffini, Ning Jia et al.|Science|2020Cited by 119
The Cas10 nuclease activity relieves host dormancy to facilitate spacer acquisition and retention during type III-A CRISPR immunityNaama Aviram, Luciano A. Marraffini|bioRxiv (Cold Spring Harbor Laboratory)|2024Cited by 2
A 5-hydroxymethylcytosine DNA glycosylase provides defense against T-even bacteriophagesAdriana Mejía-Pitta, Luciano A. Marraffini|bioRxiv (Cold Spring Harbor Laboratory)|2026Cited by 0